Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 46Sarcoma 4Other neoplasm 3Endocrine 3Thoracic 2NET 2Head & Neck 1Breast 1

Conditions

Rectal Neuroendocrine Tumors 1Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 2Lutetium-177 2Liquid Biopsy 2Endoscopic Mucosal Resection 2Data Collection 2pentetreotide 1fluorodopa F 18 1copper dotatate CU-64 1Yttrium-90 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Single Photon Emission Computed Tomography Computed Tomography 1Serum Albumin 1Robotic Surgical Procedures 1Resveratrol 1Respiratory Therapy 1Referral and Consultation 1Radiofrequency Ablation 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Palliative Care 1Octreotide 1Nutrition Assessment 1Needles 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Drug Therapy 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Endoscopic Mucosal Resection × NET × Clear all
NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT06121752 2024-10-15

DNET

Asian Institute of Gastroenterology, India

Phase NA Unknown
54 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡